Matches in Wikidata for { <http://www.wikidata.org/entity/Q46235377> ?p ?o ?g. }
- Q46235377 description "2017 nî lūn-bûn" @default.
- Q46235377 description "2017年の論文" @default.
- Q46235377 description "2017年学术文章" @default.
- Q46235377 description "2017年学术文章" @default.
- Q46235377 description "2017年学术文章" @default.
- Q46235377 description "2017年学术文章" @default.
- Q46235377 description "2017年学术文章" @default.
- Q46235377 description "2017年学术文章" @default.
- Q46235377 description "2017年學術文章" @default.
- Q46235377 description "2017年學術文章" @default.
- Q46235377 description "2017年學術文章" @default.
- Q46235377 description "2017年學術文章" @default.
- Q46235377 description "2017年學術文章" @default.
- Q46235377 description "2017년 논문" @default.
- Q46235377 description "article científic" @default.
- Q46235377 description "article scientific" @default.
- Q46235377 description "article scientifique" @default.
- Q46235377 description "articol științific" @default.
- Q46235377 description "articolo scientifico" @default.
- Q46235377 description "artigo científico" @default.
- Q46235377 description "artigo científico" @default.
- Q46235377 description "artigo científico" @default.
- Q46235377 description "artikel ilmiah" @default.
- Q46235377 description "artikull shkencor" @default.
- Q46235377 description "artikulong pang-agham" @default.
- Q46235377 description "artykuł naukowy" @default.
- Q46235377 description "artículo científico publicado en 2017" @default.
- Q46235377 description "artículu científicu" @default.
- Q46235377 description "bilimsel makale" @default.
- Q46235377 description "bài báo khoa học" @default.
- Q46235377 description "naučni članak" @default.
- Q46235377 description "scienca artikolo" @default.
- Q46235377 description "scientific article published on 13 March 2017" @default.
- Q46235377 description "scientific article published on 13 March 2017" @default.
- Q46235377 description "scientific article published on 13 March 2017" @default.
- Q46235377 description "teaduslik artikkel" @default.
- Q46235377 description "tieteellinen artikkeli" @default.
- Q46235377 description "tudományos cikk" @default.
- Q46235377 description "vedecký článok" @default.
- Q46235377 description "vetenskaplig artikel" @default.
- Q46235377 description "videnskabelig artikel" @default.
- Q46235377 description "vitenskapelig artikkel" @default.
- Q46235377 description "vitskapeleg artikkel" @default.
- Q46235377 description "vědecký článek" @default.
- Q46235377 description "wetenschappelijk artikel" @default.
- Q46235377 description "wissenschaftlicher Artikel" @default.
- Q46235377 description "επιστημονικό άρθρο" @default.
- Q46235377 description "мақолаи илмӣ" @default.
- Q46235377 description "наукова стаття, опублікована в березні 2017" @default.
- Q46235377 description "научна статия" @default.
- Q46235377 description "научная статья" @default.
- Q46235377 description "научни чланак" @default.
- Q46235377 description "научни чланак" @default.
- Q46235377 description "מאמר מדעי" @default.
- Q46235377 description "مقالة علمية نشرت في 13 مارس 2017" @default.
- Q46235377 description "১৩ মার্চ ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q46235377 description "บทความทางวิทยาศาสตร์" @default.
- Q46235377 description "სამეცნიერო სტატია" @default.
- Q46235377 name "Phase I single dose, two-period and two-sequence cross-over trial to evaluate the relative bioavailability of two oral pimasertib formulations in advanced cancer patients" @default.
- Q46235377 name "Phase I single dose, two-period and two-sequence cross-over trial to evaluate the relative bioavailability of two oral pimasertib formulations in advanced cancer patients" @default.
- Q46235377 type Item @default.
- Q46235377 label "Phase I single dose, two-period and two-sequence cross-over trial to evaluate the relative bioavailability of two oral pimasertib formulations in advanced cancer patients" @default.
- Q46235377 label "Phase I single dose, two-period and two-sequence cross-over trial to evaluate the relative bioavailability of two oral pimasertib formulations in advanced cancer patients" @default.
- Q46235377 prefLabel "Phase I single dose, two-period and two-sequence cross-over trial to evaluate the relative bioavailability of two oral pimasertib formulations in advanced cancer patients" @default.
- Q46235377 prefLabel "Phase I single dose, two-period and two-sequence cross-over trial to evaluate the relative bioavailability of two oral pimasertib formulations in advanced cancer patients" @default.
- Q46235377 P1433 Q46235377-292E8591-B04F-4FBD-8977-1DE831409B48 @default.
- Q46235377 P1476 Q46235377-BE5E13FB-E3E6-433B-B510-DE1349D0F200 @default.
- Q46235377 P2093 Q46235377-34F87E0C-0D5D-4E89-B91B-98D58418F16C @default.
- Q46235377 P2093 Q46235377-529DCB99-5AA4-4AA4-9E64-15695B439597 @default.
- Q46235377 P2093 Q46235377-6CEE972F-A88B-46D3-87C8-ACD173DE6E40 @default.
- Q46235377 P2093 Q46235377-E271B9DF-6F92-4F40-B2CF-8DE23C938AD9 @default.
- Q46235377 P2093 Q46235377-E5CEC9F0-4D5C-44D7-A6C4-14AA2A99E874 @default.
- Q46235377 P2093 Q46235377-ED821FD4-3B22-445B-B635-72D34EE7F694 @default.
- Q46235377 P2093 Q46235377-F70AB1CB-99A6-4F3D-978B-0A0DAA944EE4 @default.
- Q46235377 P2860 Q46235377-12CE5B63-0785-4FA5-BCFE-D64C45F83BFE @default.
- Q46235377 P2860 Q46235377-2ADFD091-A836-4F22-85C1-EC659B629516 @default.
- Q46235377 P2860 Q46235377-35537F2E-0BC6-418C-9FB9-9D57F00D85DB @default.
- Q46235377 P2860 Q46235377-35DE814B-92DA-40DA-9CB4-2F227DBADD1B @default.
- Q46235377 P2860 Q46235377-46CD35FD-9D4A-493B-AE9A-91C4558505BC @default.
- Q46235377 P2860 Q46235377-518D93EA-A4D1-4BDF-A698-8B2EC94EFBF6 @default.
- Q46235377 P2860 Q46235377-6C434714-F535-4432-9197-7F51D61A6A12 @default.
- Q46235377 P2860 Q46235377-7F3919F4-FE1C-47EB-8078-A0275A2C1776 @default.
- Q46235377 P2860 Q46235377-945E518D-B76F-4A81-8607-5F06E5E5325F @default.
- Q46235377 P2860 Q46235377-955A1FE4-EDD1-4961-9F27-922226465B31 @default.
- Q46235377 P2860 Q46235377-AE7BF92C-D781-4154-8572-E1C5E924AF33 @default.
- Q46235377 P2860 Q46235377-C261E571-ACE4-4FC2-9548-ADF6CA4FD5D7 @default.
- Q46235377 P2860 Q46235377-C76028DB-A45A-400E-BEA7-3A07D3FBC44E @default.
- Q46235377 P2860 Q46235377-D2A30075-9752-4E74-9F74-FE83CC15120B @default.
- Q46235377 P2860 Q46235377-DE6CDC6A-2358-45E9-BC9A-7C50FDF8F347 @default.
- Q46235377 P2860 Q46235377-ECD257B5-22F2-42EA-8246-BD3DEBEB2A5F @default.
- Q46235377 P2860 Q46235377-F30DA221-3B07-4AEF-82DD-893A6481B712 @default.
- Q46235377 P2888 Q46235377-1E55D10C-4FD5-4A5D-A95E-D33668E6E80A @default.
- Q46235377 P304 Q46235377-7C3226EC-0963-44F8-BF34-D93663D66823 @default.
- Q46235377 P31 Q46235377-662F7316-11DA-4E72-BCC9-FE1F5C0D0C28 @default.
- Q46235377 P356 Q46235377-83252986-A135-4702-80C7-8F5EBAA8C6A7 @default.
- Q46235377 P433 Q46235377-84753395-F0E0-47D9-96D0-24AC287FBD14 @default.
- Q46235377 P478 Q46235377-CD810E01-4123-4F3B-B117-E27E490CF0AA @default.
- Q46235377 P50 Q46235377-9F6701C4-E8AE-4A3C-81D0-9F63EED3E3FD @default.
- Q46235377 P577 Q46235377-4BC740FB-9374-4753-83EE-591E9CC8F33E @default.
- Q46235377 P698 Q46235377-146D5093-7F36-4255-813A-9D8D5389DF48 @default.